BE904921A - Procedes et compositions pour le traitement de troubles gastro-intestinaux. - Google Patents
Procedes et compositions pour le traitement de troubles gastro-intestinaux.Info
- Publication number
- BE904921A BE904921A BE0/216782A BE216782A BE904921A BE 904921 A BE904921 A BE 904921A BE 0/216782 A BE0/216782 A BE 0/216782A BE 216782 A BE216782 A BE 216782A BE 904921 A BE904921 A BE 904921A
- Authority
- BE
- Belgium
- Prior art keywords
- bismuth
- pref
- antimicrobial
- days
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Procédé pour le traitement d'un etre humain ou d'un animal inférieur souffrant d'un trouble gastrointestinal, caractérisé en ce que l'on administre au sujet en question d'environ 50 mg à environ 5000g de bismuth, par jour, pendant une durée de 3 à 56 jours et on administre au sujet en question une quantité sure et efficace d'un agent antimicrobien par jour, pendant une période qui fluctue de 1 à 21 jours.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74484185A | 1985-06-13 | 1985-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE904921A true BE904921A (fr) | 1986-12-15 |
Family
ID=24994175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/216782A BE904921A (fr) | 1985-06-13 | 1986-06-13 | Procedes et compositions pour le traitement de troubles gastro-intestinaux. |
Country Status (11)
Country | Link |
---|---|
EP (3) | EP0462631B1 (fr) |
JP (1) | JPH0794390B2 (fr) |
AT (3) | ATE318144T1 (fr) |
AU (1) | AU588601B2 (fr) |
BE (1) | BE904921A (fr) |
CA (1) | CA1277232C (fr) |
DE (4) | DE3686836T2 (fr) |
IE (1) | IE59583B1 (fr) |
NZ (1) | NZ216516A (fr) |
PH (1) | PH25288A (fr) |
ZA (1) | ZA864449B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986005981A1 (fr) * | 1985-04-18 | 1986-10-23 | Borody Thomas J | Traitement de la dyspepsie non ulcereuse avec des sels de bismuth |
US4959384A (en) * | 1985-10-24 | 1990-09-25 | Norwich Eaton Pharmaceuticals, Inc. | Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
DE3874917T2 (de) * | 1987-03-09 | 1993-03-04 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
EP0439453B1 (fr) * | 1987-10-12 | 1994-01-19 | Exomed Australia Pty. Ltd. (ACN 051 976 446) | Procede ameliore servant au traitement de troubles gastrointestinaux |
ATE67669T1 (de) * | 1988-10-08 | 1991-10-15 | Pfleger R Chem Fab | Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung. |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
EP0375068A1 (fr) * | 1988-12-23 | 1990-06-27 | Gist-Brocades N.V. | Associations de composés de bismuth et de tétracyclines |
DE3901508C2 (de) * | 1989-01-19 | 1994-04-07 | Falk Pharma Gmbh | Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form |
FI910088A (fi) * | 1990-01-09 | 1991-07-10 | Gist Brocades Nv | Oral farmaceutisk komposition. |
YU45590A (sh) * | 1990-03-07 | 1992-07-20 | PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. | Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje |
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
JPH06509340A (ja) * | 1991-07-24 | 1994-10-20 | ザ、プロクター、エンド、ギャンブル、カンパニー | 抗菌治療方法及び組成物 |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
AU7833194A (en) * | 1993-09-20 | 1995-04-10 | Procter & Gamble Company, The | Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection |
FR2715067B1 (fr) * | 1994-01-14 | 1996-04-05 | Ethypharm Lab Prod Ethiques | Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal. |
US5549911A (en) * | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
GB2293323A (en) * | 1994-09-12 | 1996-03-27 | Orion Yhtymae Oy | Antibiotics and bismuth salts for treating bacterial infections |
GB2292884A (en) * | 1994-09-12 | 1996-03-13 | Orion Yhtymae Oy | Rifamycin & bismuth salts for treating bacterial infections |
AUPN115095A0 (en) * | 1995-02-15 | 1995-03-09 | Butt, Henry Lawrence | Analysis of and compositions and methods for the treatment of disease |
EP0830135A1 (fr) * | 1995-05-09 | 1998-03-25 | The Procter & Gamble Company | Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux |
US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US6186958B1 (en) | 1997-02-26 | 2001-02-13 | Oridion Medical | Breath test analyzer |
US6067989A (en) * | 1997-02-26 | 2000-05-30 | Oridion Medical, Ltd. | Breath test for the diagnosis of Helicobacter pylori infection in the gastrointestinal tract |
USRE38728E1 (en) * | 1997-09-11 | 2005-04-19 | Oridion Medical, LTD | Breath test analyzer |
WO1999043327A1 (fr) * | 1998-02-24 | 1999-09-02 | Kaneka Corporation | Compositions antimicrobiennes a effet synergique, medicaments et remedes pour maladies digestives contenant ces compositions, leur procede de production et preparations associees |
DE19850445A1 (de) * | 1998-11-02 | 2000-05-04 | Falk Pharma Gmbh | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
CN104666429A (zh) * | 2013-11-28 | 2015-06-03 | 天津瑞贝特科技发展有限公司 | 治疗鸡腺胃炎的组合物及其制备方法 |
JP6487534B2 (ja) | 2014-09-05 | 2019-03-20 | シンビオミックス セラピューティクス、エルエルシー | 細菌性膣炎の治療に使用するためのセクニダゾール |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1332522A (fr) * | 1961-10-05 | 1963-07-19 | Procédé pour préparer des composés résultant de la combinaison chimique de substances antibiotiques et de substances mycocides | |
US3395212A (en) * | 1964-08-10 | 1968-07-30 | American Cyanamid Co | Neomycin and organobismuth antibacterial finish for cellulosic material |
FR6531M (fr) * | 1967-09-14 | 1968-12-09 | ||
US4153685A (en) * | 1968-11-23 | 1979-05-08 | Schering Corporation | Bismuth complex preparations |
FR2053002A1 (en) * | 1969-06-21 | 1971-04-16 | Clin Midy | Bismuth slats of alpha methiminobenzyl - penicillin |
DE1963496A1 (de) * | 1969-12-18 | 1971-06-24 | Hans Voigt Chemisch Pharmazeut | Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen |
US4118480A (en) * | 1973-02-09 | 1978-10-03 | Charles V. Stoelker | Pharmaceutical preparation for treating hemorrhoids and anal fissures |
US3903297A (en) | 1973-11-01 | 1975-09-02 | Upjohn Co | Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs |
ZA74385B (en) * | 1974-01-18 | 1975-08-27 | Gist Brocades Nv | Pharmaceutical compositions |
US4016268A (en) * | 1975-10-06 | 1977-04-05 | Morton-Norwich Products, Inc. | Method of combatting gastric ulceration |
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
PH20649A (en) * | 1981-09-22 | 1987-03-16 | Gist Brocades Nv | Bismuth containing composition and method for the preparation thereof |
US4588589A (en) * | 1983-10-13 | 1986-05-13 | Richardson-Vicks Inc. | Antidiarrheal compositions and use thereof |
WO1986005981A1 (fr) * | 1985-04-18 | 1986-10-23 | Borody Thomas J | Traitement de la dyspepsie non ulcereuse avec des sels de bismuth |
-
1986
- 1986-06-10 DE DE8686304407T patent/DE3686836T2/de not_active Expired - Lifetime
- 1986-06-10 DE DE3650504T patent/DE3650504T2/de not_active Expired - Lifetime
- 1986-06-10 DE DE3650787T patent/DE3650787T2/de not_active Expired - Lifetime
- 1986-06-10 AT AT95112838T patent/ATE318144T1/de not_active IP Right Cessation
- 1986-06-10 EP EP91114034A patent/EP0462631B1/fr not_active Expired - Lifetime
- 1986-06-10 AT AT91114034T patent/ATE135582T1/de not_active IP Right Cessation
- 1986-06-10 EP EP95112838A patent/EP0707854B1/fr not_active Expired - Lifetime
- 1986-06-10 AT AT86304407T patent/ATE81010T1/de not_active IP Right Cessation
- 1986-06-10 EP EP86304407A patent/EP0206625B1/fr not_active Expired - Lifetime
- 1986-06-12 CA CA000511416A patent/CA1277232C/fr not_active Expired - Lifetime
- 1986-06-12 IE IE157286A patent/IE59583B1/en not_active IP Right Cessation
- 1986-06-12 NZ NZ216516A patent/NZ216516A/xx unknown
- 1986-06-12 AU AU58595/86A patent/AU588601B2/en not_active Expired
- 1986-06-12 DE DE19863619702 patent/DE3619702A1/de not_active Withdrawn
- 1986-06-13 ZA ZA864449A patent/ZA864449B/xx unknown
- 1986-06-13 PH PH8633890A patent/PH25288A/en unknown
- 1986-06-13 JP JP61138037A patent/JPH0794390B2/ja not_active Expired - Lifetime
- 1986-06-13 BE BE0/216782A patent/BE904921A/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE318144T1 (de) | 2006-03-15 |
EP0462631B1 (fr) | 1996-03-20 |
PH25288A (en) | 1991-04-30 |
ATE81010T1 (de) | 1992-10-15 |
AU588601B2 (en) | 1989-09-21 |
IE861572L (en) | 1986-12-13 |
EP0206625A2 (fr) | 1986-12-30 |
AU5859586A (en) | 1986-12-18 |
DE3686836T2 (de) | 1993-03-04 |
DE3650787T2 (de) | 2006-11-16 |
NZ216516A (en) | 1989-08-29 |
JPS6248623A (ja) | 1987-03-03 |
DE3650504T2 (de) | 1996-10-31 |
EP0206625A3 (en) | 1989-04-05 |
DE3650787D1 (de) | 2006-04-27 |
EP0707854A2 (fr) | 1996-04-24 |
JPH0794390B2 (ja) | 1995-10-11 |
IE59583B1 (en) | 1994-03-09 |
DE3619702A1 (de) | 1987-02-12 |
DE3650504D1 (de) | 1996-04-25 |
EP0462631A1 (fr) | 1991-12-27 |
ATE135582T1 (de) | 1996-04-15 |
CA1277232C (fr) | 1990-12-04 |
DE3686836D1 (de) | 1992-11-05 |
ZA864449B (en) | 1987-02-25 |
EP0707854A3 (fr) | 1997-06-04 |
EP0707854B1 (fr) | 2006-02-22 |
EP0206625B1 (fr) | 1992-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE904921A (fr) | Procedes et compositions pour le traitement de troubles gastro-intestinaux. | |
Graham et al. | Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing: a randomized controlled trial | |
US5256684A (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
DE3887353T2 (de) | Behandlungsverfahren für magen-darm-krankheiten. | |
AU590578B2 (en) | Treatment of non-ulcer dyspepsia with bismuth salts | |
KR920002144A (ko) | 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제 | |
DE69125940T2 (de) | Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten | |
EP0865286B1 (fr) | Compositions destinees a la prevention et au traitement de troubles gastro-intestinaux et comprenant du bismuth ainsi qu'un ou plusieurs agents antimicrobiens | |
RU2139060C1 (ru) | Комплексный биологически активный препарат | |
Wise et al. | Cephacetrile, a new cephalosporin, in the treatment of urinary tract infections | |
US4252821A (en) | Method for treating ulcers | |
Evans Jr et al. | Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing | |
Gardikas et al. | Cefuroxime in the treatment of urinary tract infections | |
MONASH et al. | Bismuth penicillin in the treatment of acute syphilitic Orchitis of rabbits | |
Smoot et al. | Effectiveness of Ranitidine Bismuth Citrate, Clarithromycin, and Metronidazole Therapy for TreatingHelicobacter pylori | |
Scarpignato et al. | H2 Receptor Antagonists: Is There a Place in the Treatment of Helicobacter pylori Infection? | |
Study | A Fixed Combination of Pivmecillinam and Pivampicillin in Complicated Urinary Tract Infections: Double-blind Comparison with Pivmecillinam Alone in Hospitalized Patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: *MARSHALL BARRY J. Effective date: 20060613 |